Table 2.
Characteristics of the study participants
| A. Demographic characteristicsa | Interventional IMM-population | Inpatient control group | |
| (N = 99) | (N = 201) | ||
| Age | years | years | |
| Mean | 68 | 71 | |
| Standard deviation | ±15 | ±13 | |
| Range | 27-96 | 20-95 | |
| Age category | N (%) | N (%) | |
| <65 years | 35 (35 %) | 56 (28 %) | |
| >65 years | 64 (65 %) | 145 (72 %) | |
| Gender | N (%) | N (%) | |
| Male | 60 (61 %) | 122 (61 %) | |
| Female | 39 (39 %) | 79 (39 %) | |
| Skin alterations | N (%) | N (%) | |
| With skin alterations | 60 (61 %) | 136 (68 %) | |
| Without skin alterations | 39 (39 %) | 65 (32 %) | |
| B. Study entry description | |||
| Patients with entry in the study from | N (%) | N (%) | |
| Hospital | 62 (63 %) | Hospital inpatient, by default | |
| Long-term care | 12 (12 %) | ||
| Patient’s home | 25 (25 %) | ||
| Discharge location (IMM only) | |||
| Hospital | 0 | not applicable | |
| Long-term care | 22 (22 %) | ||
| Patient’s home | 77 (78 %) | ||
| Patients not completing | 6 (6 %) | 0 | |
| Protocol violations | 9 (9 %) | 0 | |
| Per protocol Set (PPS) | N = 84 | N = 54b | |
at-test (age): p > 0.05. Chi-square test (gender, skin alterations): p > 0.05
bPPS inpatient control group: LOS of 22 ± 3 decolonization days or three negative MRSA-swabs